Hedge Funds, Schmedge Funds, It's A $3 Billion Offer

Oct 12, 2007

On the Wall Street Journal health blog, Jacob Goldstein discusses the "battle" for the diagnostic company Ventana -- Roche made a hostile bid for the company earlier this year. Goldstein reports that Roche's CEO, Franz Hume, has been saying that hedge funds have bought out the leading shareholders but that Roche's $3 billion offer will eventually go through.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Same Scam, New Tech

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

Gene Therapy for SCID-X1

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

To Guide the Genealogy Search

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

This Week in Nature

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.

Menu